The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients.

Buetti, N., Tabah, A., Loiodice, A., Ruckly, S., Aslan, A.T., Montrucchio, G., et al. (2022). Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study. CRITICAL CARE, 26(1) [10.1186/s13054-022-04166-y].

Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study

Cortegiani, Andrea;
2022-01-01

Abstract

The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients.
Buetti, N., Tabah, A., Loiodice, A., Ruckly, S., Aslan, A.T., Montrucchio, G., et al. (2022). Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study. CRITICAL CARE, 26(1) [10.1186/s13054-022-04166-y].
File in questo prodotto:
File Dimensione Formato  
s13054-022-04166-y.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 1.4 MB
Formato Adobe PDF
1.4 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/575371
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact